Home Newsfeeds Barclays Maintains Equal-Weight on Amdocs, Raises Price Target to $95

Barclays Maintains Equal-Weight on Amdocs, Raises Price Target to $95

Barclays analyst Tavy Rosner maintains Amdocs (NASDAQ:DOX) with a Equal-Weight and raises the price target from $89 to $95.

byBenzinga Newsdesk

August 4, 2022

1 minute read

Barclays analyst Tavy Rosner maintains Amdocs (NASDAQ:DOX) with a Equal-Weight and raises the price target from $89 to $95.

Beverage Alcohol Company Constellation Brands’ Q2: Earnings Beat, 8.7% Beer Shipments Growth & More

By Shivani Kumaresan

October 5, 8:57 AM

Constellation Brands Inc (NYSE: STZ), an international producer and marketer of beer, wine, and spirits, reported

STZ

Shockwave Confirms Consistent Outcomes For IVL In The Largest Prospective “Real World” Study Of Patients With Heavily Calcified Peripheral Arterial Disease

By Benzinga Newsdesk

November 1, 2:58 PM

Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the final 1,373-patient cohort

SWAV

Here’s How Much You Would Have Made Owning Domino’s Pizza Stock In The Last 15 Years

By Benzinga Insights

September 13, 10:36 AM

Domino's Pizza (NYSE:DPZ) has outperformed the market over the past 15 years by 15.54% on an annualized basis producing an average annual return of 22.15%. Currently, Domino's Pizza has a market capitalization of $12.67 billion.

DPZ